ICVXIcosavax, Inc.

Nasdaq icosavax.com


$ 15.34 $ -0.14 (-0.91 %)    

Friday, 16-Feb-2024 15:59:50 EST
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 15.31
$ 15.34
$ 0.00 x 0
$ 0.00 x 0
$ 15.28 - $ 15.43
$ 4.75 - $ 16.11
9,315,217
na
765.97M
$ 0.77
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-14-2023 09-30-2023 10-Q
2 08-14-2023 06-30-2023 10-Q
3 05-10-2023 03-31-2023 10-Q
4 03-30-2023 12-31-2022 10-K
5 11-14-2022 09-30-2022 10-Q
6 08-15-2022 06-30-2022 10-Q
7 05-16-2022 03-31-2022 10-Q
8 03-30-2022 12-31-2021 10-K
9 11-15-2021 09-30-2021 10-Q
10 09-13-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 guggenheim-downgrades-icosavax-to-neutral

Guggenheim analyst Seamus Fernandez downgrades Icosavax (NASDAQ:ICVX) from Buy to Neutral.

 crude-oil-down-4-aditxt-shares-spike-higher

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 100 points on Tuesday. The Dow trad...

 why-johnson-controls-international-shares-are-trading-lower-by-over-6-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Johnson Controls International plc (NYSE: JCI) moved lower during Tuesday’s session following weak quarterly results.

 dow-jumps-over-100-points-oracle-posts-mixed-q2-results

U.S. stocks turned higher midway through trading, with the Dow Jones index gaining more than 100 points on Tuesday. The Dow tr...

 blue-bird-posts-upbeat-results-joins-oil-dri-corporation-of-america-eagle-bulk-shipping-and-other-big-stocks-moving-higher-on-tuesday

U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Tuesday.

 why-icosavax-shares-are-trading-higher-by-around-45-here-are-20-stocks-moving-premarket

Shares of Icosavax, Inc. (NASDAQ: ICVX) rose sharply in pre-market trading after AstraZeneca announced plans to buy Icosavax ...

 astrazeneca-to-acquire-us-respiratory-vaccine-player-icosavax-for-over-800m

AstraZeneca Plc (NASDAQ: AZN) has agreed to acquire Icosavax Inc (NASDAQ: ICVX) at $15.00 per share in cash at closing, plus a ...

 icosavax-announces-topline-interim-phase-2-results-for-combination-vlp-vaccine-candidate-ivx-a12-against-rsv-and-hmpv-in-older-adults

Icosavax, Inc. (NASDAQ:ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technolo...

Core News & Articles

Icosavax, Inc. (NASDAQ:ICVX) today announced it has entered into a definitive agreement pursuant to which AstraZeneca, through ...

 ross-stores-reports-strong-earnings-joins-buckle-twist-bioscience-and-other-big-stocks-moving-higher-on-friday

U.S. stocks traded mostly lower, with the Dow Jones falling over 20 points on Friday.

 guggenheim-initiates-coverage-on-icosavax-with-buy-rating-announces-price-target-of-28

Guggenheim analyst Seamus Fernandez initiates coverage on Icosavax (NASDAQ:ICVX) with a Buy rating and announces Price Targe...

 why-shapeways-holdings-shares-are-trading-lower-by-around-20-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Shapeways Holdings, Inc. (NASDAQ: SHPW) tumbled during Wednesday’s session following downbeat results.

 target-reports-earnings-beat-joins-ast-spacemobile-dada-nexus-and-other-big-stocks-moving-higher-on-wednesday

U.S. stocks traded higher, with the Dow Jones gaining more than 100 points on Wednesday. Shares of Target Corporation (NYSE: T...

 icosavax-q3-eps-044-beats-057-estimate

Icosavax (NASDAQ:ICVX) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(0.57) by 2...

 oppenheimer-reiterates-outperform-on-icosavax-maintains-25-price-target

Oppenheimer analyst Hartaj Singh reiterates Icosavax (NASDAQ:ICVX) with a Outperform and maintains $25 price target.

 icosavax-q2-eps-059-beats-060-estimate

Icosavax (NASDAQ:ICVX) reported quarterly losses of $(0.59) per share which beat the analyst consensus estimate of $(0.60) by 1...

 icosavax-reports-positive-12-month-durability-data-for-vlp-vaccine-candidate-ivx-121

In new data from Icosavax’s IVX-121 Phase 1b extension trial in older adults, GMTs against RSV through day 365 persisted at ~45...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION